Cargando…

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice

PURPOSE: The common tool for diagnosing prostate cancer is serum prostate-specific antigen (PSA) testing and digital rectal examination, but the disadvantage of the high sensitivity and low specificity of PSA testing in the diagnosis of prostate cancer is a problem in clinical practice. We studied t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lojanapiwat, Bannakij, Anutrakulchai, Wisan, Chongruksut, Wilaiwan, Udomphot, Chaichawan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society (APPS) 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186957/ https://www.ncbi.nlm.nih.gov/pubmed/25325025 http://dx.doi.org/10.12954/PI.14054

Ejemplares similares

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4–10 ng/mL and negative digital rectal examination
por: Sriplakich, Supon, et al.
Publicado: (2018)

Guy's Stone Score (GSS) Based on Intravenous Pyelogram (IVP) Findings Predicting Upper Pole Access Percutaneous Nephrolithotomy (PCNL) Outcomes
por: Lojanapiwat, Bannakij, et al.
Publicado: (2016)

The ideal puncture approach for PCNL: Fluoroscopy, ultrasound or endoscopy?
por: Lojanapiwat, Bannakij
Publicado: (2013)

Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience
por: Ditsatham, Chagkrit, et al.
Publicado: (2019)

The efficacy of peritubal analgesic infiltration in postoperative pain following percutaneous nephrolithotomy – A prospective randomized controlled study
por: Lojanapiwat, Bannakij, et al.
Publicado: (2015)

Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis
por: Xiao, Guang-Qian, et al.
Publicado: (2015)

Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand
por: Lojanapiwat, Bannakij, et al.
Publicado: (2017)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review
por: Zhang, Xu, et al.
Publicado: (2023)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
por: Olivan, Mireia, et al.
Publicado: (2021)

Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2012)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
por: Koo, Kyo Chul, et al.
Publicado: (2015)

Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma
por: Chen, Yehui, et al.
Publicado: (2017)

From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011)

Endothelin-1 Expression in Prostate Needle Biopsy Specimens Correlated With Aggressiveness of Prostatic Cancer
por: Asgari, Mojgan, et al.
Publicado: (2017)

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis
por: Hagaman, Daniel E., et al.
Publicado: (2021)

Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer
por: Kamel, Mohamed H., et al.
Publicado: (2018)

Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis
por: Strömvall, Kerstin, et al.
Publicado: (2017)

Isolated brain metastasis of prostate carcinoma in the setting of normal prostate specific antigen
por: Campagna, Justin P., et al.
Publicado: (2018)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020)

The Diagnostic Accuracy of Prostate-Specific Antigen and Digital Rectal Examination in the Diagnosis of Prostate Cancer at the University of Benin Teaching Hospital
por: Ozah, Ehiremhen, et al.
Publicado: (2023)

Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies
por: Liu, Fanxiao, et al.
Publicado: (2021)

Necrotizing fasciitis: epidemiology and clinical predictors for amputation
por: Khamnuan, Patcharin, et al.
Publicado: (2015)

Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand
por: Khamnuan, Patcharin, et al.
Publicado: (2015)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
por: Amoako, Yaw Ampem, et al.
Publicado: (2019)

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
por: Hammond, Emmanuel Nii Boye, et al.
Publicado: (2021)

Cellular Plasticity in Prostate Cancer Bone Metastasis
por: Jadaan, Dima Y., et al.
Publicado: (2015)

Prostate Cancer Presenting with Parietal Bone Metastasis
por: Kirakoya, Brahima, et al.
Publicado: (2017)

Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase
por: Quiroz-Munoz, Mariana, et al.
Publicado: (2019)

Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis
por: Wang, Wenying, et al.
Publicado: (2014)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
por: Kim, Jun Seok, et al.
Publicado: (2015)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer
por: Bossan, Alexia, et al.
Publicado: (2018)

Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer
por: Grenville, Zoe S., et al.
Publicado: (2022)

Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis
por: Vermassen, Tijl, et al.
Publicado: (2015)

Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis
por: Di Francesco, Simona, et al.
Publicado: (2013)

Dissociation of bone formation markers in bone metastasis of prostate cancer.
por: Koizumi, M., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_68skec6s1j8p520f87nnle6m7s